Asset Advisors Investment Management, LLC Amgen Inc Transaction History

Asset Advisors Investment Management, LLC

$890 Million
Q1 2024

A detailed history of Asset Advisors Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Asset Advisors Investment Management, LLC holds 32,151 shares of AMGN stock, worth $9.95 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

32,151

Previous 31,761 1.23%

Holding current value

$9.95 Million

Previous $9.15 Million 0.07%

% of portfolio

1.03%

Previous 1.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $104,859 - $126,578	390 Added 1.23%	32,151 $9.14 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $212,998 - $240,287	833 Added 2.69%	31,761 $9.15 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $38,919 - $48,319	-178 Reduced 0.57%	30,928 $8.31 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $332,118 - $392,723	-1,550 Reduced 4.75%	31,106 $6.91 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $597,666 - $728,454	-2,647 Reduced 7.5%	32,656 $7.89 Million

Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $351,561 - $446,700	1,535 Added 4.55%	35,303 $9.27 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $501,668 - $565,790	2,235 Added 7.09%	33,768 $7.61 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $193,796 - $215,661	840 Added 2.74%	31,533 $7.67 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $3.31 Million - $3.67 Million	15,111 Added 96.98%	30,693 $7.42 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $41,764 - $47,796	210 Added 1.37%	15,582 $3.51 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $4.2 Million - $4.93 Million	-19,804 Reduced 56.3%	15,372 $3.27 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $53,022 - $58,824	227 Added 0.65%	35,176 $8.57 Million
Q1 2021 Apr 15, 2021	BUY	$221.91 - $258.6 $609,142 - $709,857	2,745 Added 8.52%	34,949 $8.7 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $236,503 - $281,633	1,093 Added 3.51%	32,204 $7.4 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $226,437 - $251,816	-965 Reduced 3.01%	31,111 $7.91 Million
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $275,153 - $337,651	-1,391 Reduced 4.16%	32,076 $7.57 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $3,644 - $4,834	20 Added 0.06%	33,467 $6.79 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $69,061 - $88,768	365 Added 1.1%	33,447 $8.03 Million
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $974,145 - $1.17 Million	5,595 Added 20.36%	33,082 $6.4 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $215,876 - $253,055	1,295 Added 4.94%	27,487 $5.07 Million
Q1 2019 Apr 16, 2019	BUY	$180.87 - $203.88 $29,120 - $32,824	161 Added 0.62%	26,192 $4.98 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $289,008 - $337,365	-1,620 Reduced 5.86%	26,031 $5.07 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $5.12 Million - $5.78 Million	27,651 New	27,651 $5.73 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.

Account

Asset Advisors Investment Management, LLC Amgen Inc Transaction History